GT Biopharma, Inc. short interest in 2024
In 2024, GT Biopharma, Inc.'s disclosed short interest ran from 0.14% of shares outstanding on 12 Jan 2024 to 0.61% on 13 Dec 2024, a change of +0.47 percentage points. The year's high was 0.87% on 15 Nov 2024 and its low 0.06% on 31 Jan 2024, averaging 0.47% across 14 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.59 days on 15 Aug 2024. Full history: GT Biopharma, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.14% (12 Jan 2024)
- End of year
- 0.61% (13 Dec 2024)
- Change
- +0.47 pp
- High
- 0.87% (15 Nov 2024)
- Low
- 0.06% (31 Jan 2024)
- Average
- 0.47%
- Highest days to cover
- 1.59 (15 Aug 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 0.14% | 1.00 | |
| 31 Jan 2024 | 0.06% | 1.00 | |
| 28 Mar 2024 | 0.63% | 1.00 | 10-K filed |
| 30 Apr 2024 | 0.43% | 1.00 | |
| 15 May 2024 | 0.20% | 1.00 | 10-Q filed |
| 15 Aug 2024 | 0.86% | 1.59 | 10-Q filed |
| 30 Aug 2024 | 0.42% | 1.12 | |
| 13 Sep 2024 | 0.35% | 1.01 | |
| 30 Sep 2024 | 0.22% | 1.00 | |
| 15 Oct 2024 | 0.46% | 1.00 | |
| 31 Oct 2024 | 0.79% | 1.00 | |
| 15 Nov 2024 | 0.87% | 1.00 | 10-Q filed |
| 29 Nov 2024 | 0.50% | 1.00 | |
| 13 Dec 2024 | 0.61% | 1.00 |
See also: GT Biopharma, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.